Axle Health is a healthcare technology company on a mission to revolutionize home-based care delivery through its comprehensive operations platform. Founded in 2020 by healthcare and technology veterans, including several former Uber executives who brought their logistics expertise to the healthcare industry, Axle Health’s AI-powered logistics platform enables healthcare organizations to efficiently deploy clinicians for in-home visits, improving patient outcomes while reducing operational costs. The company is headquartered in Los Angeles, California.
Countable Labs
Countable Labs is redefining PCR with single-molecule precision and category-defining sensitivity, overcoming the limitations of legacy technologies. Countable PCR delivers 10 times the sensitivity and precision of digital PCR in a single reaction. Plus, it speeds up assay development with simplified multiplexing. These breakthroughs unlock high-sensitivity applications that were previously impractical due to cost and complexity.
Insmed
Insmed Incorporated is a biopharmaceutical firm focused on developing therapies for serious and rare diseases, including respiratory and inflammatory conditions. Its flagship product, Arikayce, targets treatment-refractory Mycobacterium avium complex lung disease.
Peptone
Peptone is an innovative drug discovery company applying advanced biophysics, atomic-level experimental approaches, cutting-edge supercomputing and machine learning to the challenge of biopharmaceutical research and development. By bringing these proprietary approaches together, Peptone is exploring the world of intrinsically disordered proteins (IDPs) – proteins without a fixed structure that play a significant role in health and disease – opening up the possibility of novel therapeutics against this class of high value and previously undruggable targets.
TripSuite
TripSuite is the most comprehensive software for travel agencies. From CRM to commission tracking and accounting, the company provides a modern solution for travel agencies.
Oxio
Oxio is a US-based “telecom-as-a-service” company that provides telecom carriers with a new channel to distribute network capacity to businesses built on Web3 technology and principles. Unlike traditional Mobile Virtual Network Operators (MVNOs), Oxio is making this telecom network capacity available to business clients via direct software API connections. This enables businesses to offer branded telecom connectivity solutions to their customers in return for uniquely valuable customer insights.
Beads
Beads specializes in offering a residential facility for end-of-life care for people who suffer from terminal cancer or intractable neurological diseases, enabling patients to spend their time in a comfortable way.
RhyGaze
RhyGaze is a cutting-edge biotechnology company based in Basel, Switzerland, and Philadelphia, Pa., USA, focused on developing gene therapies for retinal diseases causing blindness. Founded on pioneering research from the Institute of Molecular and Clinical Ophthalmology Basel (IOB), RhyGaze aims to restore vision and transform the lives of patients worldwide. IOB scientists Drs. Botond Roska, Bence György and Charles Gubser are the scientific founders of RhyGaze.
Tenvie Therapeutics
Tenvie is a biotechnology company committed to engineering small molecules that transform the treatment of neurological diseases. The company’s foundation is purpose-built with a diverse portfolio of small molecules and a proven team of CNS drug developers to rapidly deliver multiple clinical assets. Tenvie is advancing a pipeline of therapeutics focused on treating neurological, cardiometabolic, and ophthalmic diseases. Its portfolio of wholly owned, highly brain-penetrant, and precision-designed peripherally restricted small molecules address three key drivers of disease: resolving inflammation, rescuing metabolic dysfunction, and restoring lysosomal function. The company’s most advanced programs target NLRP3 and SARM1, with additional programs in preclinical development. You can follow Tenvie on LinkedIn.
OncoveryCare
OncoveryCare delivers comprehensive, whole-person care to cancer survivors. As the population of survivors grows rapidly alongside advances in medicine, OncoveryCare provides the personalized, longitudinal care that cancer survivors need to lead happier, healthier lives. Founded by a breast cancer survivor and led by both clinicians and survivors, OncoveryCare’s first offering is a novel Cancer Transitions of Care program, equipping each survivor with a survivorship-trained clinical team and the essential tools and skills they need to actively manage their survivorship journey.